Citigroup
C
Chevron
CVX
The Kraft Heinz
KHC
DaVita
DVA
Apple
AAPL
US Stock MarketDetailed Quotes
MYGN Myriad Genetics
- 12.390
- -0.130-1.04%
Close Jan 17 16:00 ET
- 12.390
- 0.0000.00%
Post 16:42 ET
1.13BMarket Cap-9.68P/E (TTM)
12.835High12.210Low932.81KVolume12.560Open12.520Pre Close11.56MTurnover1.11%Turnover RatioLossP/E (Static)91.04MShares29.30052wk High1.54P/B1.04BFloat Cap12.17052wk Low--Dividend TTM83.95MShs Float69.000Historical High--Div YieldTTM4.99%Amplitude1.438Historical Low12.390Avg Price1Lot Size
Myriad Genetics News
Myriad Genetics | 10-Q: Q3 2024 Earnings Report
Myriad Genetics | 10-Q: Q2 2024 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Strong Second Quarter 2024 Financial Results, including 15% Revenue Growth Year-Over-Year; Raises 2024 Financial Guidance and Long-Term Revenue Growth Target to 12%
Myriad Genetics | 10-Q: Q1 2024 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Strong First Quarter 2024 Financial Results; Achieves 12% Revenue Growth Year-Over-Year; Significantly Improved Year-Over-Year Net Loss and Generated Positive Adjusted EBITDA
Myriad Genetics | 10-K: FY2023 Annual Report
Myriad Genetics | 10-Q: Q3 2023 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Third Quarter 2023 Financial Results; Generates Double-Digit Revenue Growth ; Raises 20 23 Revenue Guidance andIntroduces 2024 Revenue Guidance
Myriad Genetics | 10-Q: Q2 2023 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Second Quarter 2023 Financial Results and Reaffirms 2023 Revenue and Adjusted EPS Guidance; Generates the Fourth Consecutive Quarter of Double-Digit Year-Over-Year Testing Volume Growth
Myriad Genetics | 10-Q: Q1 2023 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports First Quarter 2023 Financial Results; Achieves 10% Revenue Growth Year-Over-Year, the Second Consecutive Quarter of Double-Digit Year-Over-Year Revenue Growth; Raises Mid-Point of 2023 Revenue Guidance Range
Myriad Genetics | 10-K: FY2022 Annual Report
Myriad Genetics | 8-K: Myriad Genetics Reports Fourth Quarter Financial Results; Fourth Quarter Revenue of $177.8 Million Grew 11% Year-Over-Year Driven by 16% Growth in Hereditary Cancer Volumes and 23% Growth in GeneSight ® Volumes
Myriad Genetics | 10-Q: Q3 2022 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Third Quarter Financial Results
Myriad Genetics | 10-Q: Q2 2022 Earnings Report
Myriad Genetics | 8-K: Myriad Genetics Reports Second Quarter Financial Results
Myriad Genetics | 10-Q: Q1 2022 Earnings Report
Myriad Genetics | 10-K: FY2021 Annual Report
Trending US Stocks
Warren Buffett Portfolio Warren Buffett Portfolio
Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry. Buffett's holdings are the latest portfolio from Berkshire Hathaway. Regarded as a top investor, his trades often signal the market and influence the industry.